Document is current
Any future updates will be listed below
-
Authors
Cao, Xueqi https://orcid.org/0009-0005-9019-0403
Huber, Sandra
Ahari, Ata Jadid
Traube, Franziska R. https://orcid.org/0000-0002-5691-1941
Seifert, Marc
Oakes, Christopher C.
Secheyko, Polina
Vilov, Sergey https://orcid.org/0000-0002-2609-1356
Scheller, Ines F. https://orcid.org/0000-0003-4533-7857
Wagner, Nils
Yépez, Vicente A. https://orcid.org/0000-0001-7916-3643
Blombery, Piers
Haferlach, Torsten
Heinig, Matthias https://orcid.org/0000-0002-5612-1720
Wachutka, Leonhard https://orcid.org/0000-0002-5959-040X
Hutter, Stephan
Gagneur, Julien https://orcid.org/0000-0002-8924-8365
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (031L0203B, 031L0203B, 031L0203C, 031L0203C, 031L0203A, 031L0203A)
EVUK programme
Technische Universität München
- License Information
-
More Information
Article History
Received: 29 September 2023
Accepted: 4 April 2024
First Online: 20 May 2024
Declarations
:
: All patients or their legal guardians gave written informed consent for genetic analyses and to the use of laboratory results and clinical data for research purposes, according to the Declaration of Helsinki. The consent can be found at: .The study was approved by the MLL’s institutional review board and by the Bavarian Ethics Committee, the Bavarian State Medical Association (Bayerische Landesärztekammer) with number 05117.
: Not applicable.
: T.H. declares part ownership of Munich Leukemia Laboratory (MLL). Sa.H. and St.H. are employed by the MLL. The remaining authors declare that they have no competing interests.
